Large-scale testing (Phase 3)Study completedNCT00434733
What this trial is testing
Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
Who this might be right for
Influenza
Novartis 4,400